跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,253 条关于
“Takayasu arteritis”
全部
6,253
临床试验
6,042
药物
44
机构
4
资讯
163
去年
AbbVie's Rinvoq Achieves Breakthrough Results in Alopecia Areata Phase III Trial
11个月前
FDA Approves Expanded RINVOQ Label for IBD Treatment, Allowing Earlier Use When TNF Blockers Inadvisable
去年
RINVOQ (Upadacitinib) Demonstrates Efficacy in Atopic Dermatitis with Head and Neck Involvement: Phase III Trial Analysis
去年
AbbVie's RINVOQ Receives Positive CHMP Opinion for Giant Cell Arteritis Treatment
去年
CHMP Backs AbbVie's Rinvoq for Giant Cell Arteritis Treatment in Adults
去年
Upadacitinib Shows Promise in Treating Giant Cell Arteritis
去年
Novartis' Cosentyx Fails to Meet Primary Endpoint in Phase III Giant Cell Arteritis Trial
2年前
Novartis Cosentyx Fails to Meet Primary Endpoint in Phase III Giant Cell Arteritis Trial
11个月前
AbbVie's Rinvoq Becomes First Oral JAK Inhibitor Approved for Giant Cell Arteritis as Novartis' Cosentyx Fails Phase III Trial
去年
Recombinant Zoster Vaccine Shows Strong Efficacy and Safety Profile in Rheumatoid Arthritis Patients
第 1 页,共 17 页
上一页
下一页